The influence of microenvironmental factors during cancer therapy.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  In Vivo

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  PMID 7727714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis.

  2024cites this paper
• Insight into Tumor Hypoxia: Radionuclide-based Biomarker as Diagnostic Tools.

  2023cites this paper
• Large scale in vivo micro‐RNA loss of function screen identified miR‐29a, miR‐100 and miR‐155 as modulators of radioresistance and tumor‐stroma communication

  2019cites this paper
• Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures

  2019cites this paper
• Impact of Cancer-Associated Fibroblast on the Radiation-Response of Solid Xenograft Tumors

  2019cites this paper
• Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.

  2019cites this paper
• Identification of radiation‐induced EndMT inhibitors through cell‐based phenomic screening

  2018cites this paper
• Intra- and Inter-Modality Registration for Validation of MRI based Hypoxia Imaging

  2018cites this paper
• Analysis of potential driver genes in oral squamous cell carcinoma

  2018cites this paper
• A history of exploring cancer in context

  2018cites this paper
• Titre : Title : Switching between magnetotactic and aerotactic displacement controls to enhance the efficacy of MC-1 magneto-aerotactic bacteria as cancer-fighting nanorobots Auteurs :

  2018cites this paper
• The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer

  2017cites this paper
• Phase I study of evofosfamide, an investigational hypoxia‐activated prodrug, in patients with advanced leukemia

  2016cites this paper
• Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts

  2016cites this paper
• Applications of "Hot" and "Cold" Bis(thiosemicarbazonato) Metal Complexes in Multimodal Imaging.

  2016cites this paper
• Hypoxia-directed and activated theranostic agent: Imaging and treatment of solid tumor.

  2016cites this paper
• Switching between Magnetotactic and Aerotactic Displacement Controls to Enhance the Efficacy of MC-1 Magneto-Aerotactic Bacteria as Cancer-Fighting Nanorobots

  2016cites this paper
• Novel Antibody-Targeted Liposomes for the Treatment of Solid Tumors

  2016cites this paper
• The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis.

  2015cites this paper
• The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

  2015cites this paper
• Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models

  2015cites this paper
• Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence.

  2015cites this paper
• Investigation into the hypoxia-dependent cytotoxicity of anticancer drugs under oxygen gradient in a microfluidic device

  2015cites this paper
• Alternation of adriamycin penetration kinetics in MCF-7 cells from 2D to 3D culture based on P-gp expression through the Chk2/p53/NF-κB pathway.

  2015cites this paper
• Development of therapeutic strategies for quiescent tumor cell populations

  2015cites this paper
• Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF‐1α and glycolysis, by inhibiting PI3K/Akt signaling pathway

  2014cites this paper
• Manipulating the Tumor Microenvironment for Therapeutic Benefit

  2014cites this paper
• 3D tumor models: history, advances and future perspectives.

  2014cites this paper
• Magnetic therapeutic delivery using navigable agents.

  2014cites this paper
• The Requirement for Oxygen in the Maturation and Secretion of Soluble urokinase Plasminogen Activator Receptor (uPAR)

  2013cites this paper
• Modulation of regulators of cellular pH in Small Cell Lung Cancer cells by chemotherapeutic drugs

  2013cites this paper
• Ablation of Hypoxic Tumors with Dose-Equivalent Photothermal, but Not Photodynamic, Therapy Using a Nanostructured Porphyrin Assembly

  2013cites this paper
• Focal Adhesion-Chromatin Linkage Controls Tumor Cell Resistance to Radio- and Chemotherapy

  2012influential citation
• Hypoxia in Head and Neck Squamous Cell Carcinoma

  2012cites this paper
• Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells

  2011cites this paper
• Discovery and Optimisation of Bacterial Nitroreductases for Use in Anti-Cancer Gene Therapy

  2011cites this paper
• Gene Therapy Strategy for Tumour Hypoxia

  2011cites this paper
• A study of anti-cancer effects of Funalia trogii in vitro and in vivo.

  2011cites this paper
• Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.

  2011cites this paper
• Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy

  2011cites this paper
• The Effect of Hypoxia on the Production of Interleukin-10 (IL-10) In Human Mononuclear Cells

  2010cites this paper
• Biomolecular Markers in Cancer of the Tongue

  2009cites this paper
• Use of non-pathogenic bacteria as vectors for targeted gene expression cancer gene therapy

  2009cites this paper
• iNOS as a therapeutic target for treatment of human tumors.

  2008cites this paper
• Targeting tumour hypoxia in breast cancer.

  2008cites this paper
• Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.

  2008cites this paper
• Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.

  2008cites this paper
• The multifactorial nature of hypoxia-induced drug resistance in cancer: involvement of hypoxia-inducible factor 1

  2008cites this paper
• Pharmacokinetic/pharmacodynamic model-guided identification of hypoxia-selective 1,2,4-benzotriazine 1,4-dioxides with antitumor activity: the role of extravascular transport.

  2007cites this paper
• Targeting the molecular effects of a hypoxic tumor microenvironment.

  2007cites this paper
• Tumor hypoxia in cancer therapy.

  2007cites this paper
• [The effect of oxygenation on the biological behaviour of tumours].

  2007cites this paper
• Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity.

  2007cites this paper
• Analysis of the hypoxia-activated dinitrobenzamide mustard phosphate pre-prodrug PR-104 and its alcohol metabolite PR-104A in plasma and tissues by liquid chromatography-mass spectrometry.

  2007cites this paper
• The use of clostridial spores for cancer treatment

  2006cites this paper
• Multiceli Spheroid Response to Drugs Predicted with the Comet Assay1

  2006cites this paper
• The Met pathway: master switch and drug target in cancer progression

  2006cites this paper
• The impact of anaemia on outcome in cancer.

  2005cites this paper
• Role of stat3 in regulating hif-1alpha expression and tumor angiogenesis

  2005cites this paper
• BASIC SCIENCE REVIEW

  2005cites this paper
• Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications

  2004cites this paper
• Relevance of tumor microenvironment for progression, therapy and drug development.

  2004cites this paper
• A Novel Bis‐aziridinylnaphthoquinone with Anti‐Solid Tumor Activity in which Induced Apoptosis is Associated with Altered Expression Of Bcl‐2 Protein

  2004cites this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cites this paper
• HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.

  2004cites this paper
• Neuroblastoma survival and death: an in vitro model of hypoxia and metabolic stress.

  2004cites this paper
• Induced differentiation affords neuroblastoma cells protection from hypoxic injury.

  2003cites this paper
• Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.

  2003cites this paper
• Tumor hypoxia: A target for selective cancer therapy

  2003cites this paper
• Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro

  2003cites this paper
• Hypoxia as a target for combined modality treatments.

  2002cites this paper
• Tumor Microenvironment and the Response to Anticancer Therapy

  2002cites this paper
• Biological Predictors of Response to Radiotherapy in Head and Neck Cancer: Recent Advances and Emerging Perspectives

  2001cites this paper
• Treatment resistance of solid tumors: role of hypoxia and anemia.

  2001cites this paper
• Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity

  2001cites this paper
• Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors.

  2001cites this paper
• Use of green fluorescent protein to mark hypoxic tumour cells

  2001cites this paper
• Exploiting Tumor Hypoxia in the Treatment of Solid Tumors

  2001cites this paper
• Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

  2001cites this paper
• Tumor radiosensitivity: it's the subpopulations that count.

  2000cites this paper
• Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies.

  2000cites this paper
• Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice.

  2000cites this paper
• Hypoxic cytotoxic agents: a new approach to cancer chemotherapy.

  2000cites this paper
• Modelling extravascular drug penetration using multilayered cell cultures

  1999cites this paper
• Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin

  1999influential citation
• The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

  1999cites this paper
• Heterogeneity of in vitro radiosensitivity in human bladder cancer cells.

  1999cites this paper
• Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?

  1999cites this paper
• The TdT‐mediated dUTP Nick End Labeling Assay Precisely Assesses the DNA Damage in Human Tumor Xenografts

  1998cites this paper
• The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

  1998cites this paper
• Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity.

  1997cites this paper
• Less death in the dying

  1997cites this paper
• Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice.

  1997cites this paper
• Detection of subpopulations resistant to DNA-damaging agents in spheroids and murine tumours.

  1997cites this paper
• Tumor repopulation during radiotheraphy: quantitation in two xenografted human tumors.

  1997cites this paper
• Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.

  1996cites this paper
• Hypoxia-Specific Cytotoxins in Cancer Therapy.

  1996cites this paper
• Growth and radiation response of cells grown in macroporous gelatin microcarriers (CultiSpher-G).

  1996cites this paper